📰 Survivorship Program News
Page 2 - Survivorship Program News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Survivorship Program. Real-time updates on events, politics, business and more.
August 24, 2023
Dr. Denlinger is currently NCCNs Chief Scientific Officer and previously served as Chair and Member of multiple NCCN Guidelines Panels—in charge of maintaining gold-standard evidence-based expert consensus cancer treatment recommendations.Today the
June 27, 2023
BURLINGTON – More than 1,250 participants stepped up to support the Lahey Cancer Institute 5K Walk & Run on June 11, raising over $279,000 to fund services and resources for
June 3, 2023
Patients with nonmetastatic castration-resistant prostate cancer who received darolutamide were observed to have a longer time to treatment discontinuation and progression to metastatic castration-resistant disease than those who received enzalutamide or apalutamide.
May 12, 2023
The Fred Hutch Survivorship Program along with Seattle Children's Hospital is hosting the Pediatric Moving Beyond Cancer to Wellness event designed for pediatric, adolescent and young adult cancer patients, survivors, caregivers, friends and family.
March 29, 2023
Following a cancer diagnosis, the Providence breast patient navigator steps in to help guide patients like Becky Stone through the healthcare system.
February 16, 2023
Phase 2b/3 study may proceed under U.S. Investigational New Drug applicationStudy design now accepted by U.S. and U.K. regulatory authoritiesAxcella to present at Long COVID forum co-sponsored by BIO and Solve M.E.Axcella to host a conference call February 16 at 8:00 a.m. ET; To register, click hereCAMBRIDGE, Mass.-...
November 23, 2022
A number of musicians and other entertainers have been severely debilitated as a result of long COVID.
October 13, 2022
Michael B. Harris, M.D., Professorship Established at Hackensack Meridian School of Medicine and The Children’s Cancer Institute Thanks to $1 Million Gift fro
July 7, 2022
Acclaimed oncologist and immunotherapy expert Neal Flomenberg, M.D. joins Tevogen Bio as Chief Scientific Officer (CSO) and Global Head of Research & DevelopmentDr. Flomenberg most recently served as Professor and Chairman of the Department of Medical Oncology and Deputy Director of Sidney Kimmel Cancer Center of Th...
July 7, 2022
Tevogen Bio appointed Dr. Neal Flomenberg as chief scientific officer and global head of research and development.